Document:

Exhibit 10.1

 

AGORA DIGITAL HOLDINGS, INC.

2021 EQUITY INCENTIVE PLAN

 

1. Scope of Plan; Definitions.

 

(a) This 2021 Equity Incentive
Plan (the “Plan”) is intended to advance the interests of Agora Digital Holdings, Inc. (the “Company”) and its
Related Corporations by enhancing the ability of the Company to attract and retain qualified employees, consultants, Officers and directors,
by creating incentives and rewards for their contributions to the success of the Company and its Related Corporations. This Plan will
provide to (a) Officers and other employees of the Company and its Related Corporations opportunities to purchase common stock, par value
$0.001 (“Common Stock”) of the Company pursuant to Options granted hereunder which qualify as incentive stock options (“ISOs”)
under Section 422(b) of the Internal Revenue Code of 1986 (the “Code”), (b) directors, Officers, employees and consultants
of the Company and Related Corporations opportunities to purchase Common Stock of the Company pursuant to options granted hereunder which
do not qualify as ISOs (“Non-Qualified Options”); (c) directors, Officers, employees and consultants of the Company and Related
Corporations opportunities to receive shares of Common Stock of the Company which normally are subject to restrictions on sale (“Restricted
Stock”); (d) directors, Officers, employees and consultants of the Company and Related Corporations opportunities to receive grants
of stock appreciation rights (“SARs”); and (e) directors, Officers, employees and consultants of the Company and Related Corporations
opportunities to receive grants of restricted stock units (“RSUs”). ISOs and Non-Qualified Options are referred to hereafter
as “Options.” Options, Restricted Stock, RSUs and SARs are sometimes referred to hereafter collectively as “Stock Rights.”
Any of the Options and/or Stock Rights may in the Board of Directors’ or Compensation Committee’s discretion be issued in
tandem to one or more other Options and/or Stock Rights to the extent permitted by law.

 

(b) For purposes of the Plan,
capitalized words and terms shall have the following meaning:

 

“Board” means the
board of directors of the Company.

 

“Chairman” means
the chairman of the Board.

 

“Change of Control”
means the occurrence of any of the following events: (i) the consummation of the sale or disposition by the Company of all or substantially
all of the Company’s assets in a transaction which requires shareholder approval under applicable state law; or (ii) the consummation
of a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the
voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by
being converted into voting securities of the surviving entity or its parent) at least 50% of the total voting power represented by the
voting securities of the Company or such surviving entity or its parent outstanding immediately after such merger or consolidation.

 

“Code” shall have
the meaning given to it in Section 1(a).

 

“Common Stock”
shall have the meaning given to it in Section 1(a).

 

     

     

    

 

“Company” shall
have the meaning given to it in Section 1(a).

 

“Compensation Committee”
means the compensation committee of the Board, if any, which shall consist of two or more members of the Board, each of whom shall be
both an “outside director” within the meaning of Section 162(m) of the Code and a “non-employee director” within
the meaning of Rule 16b-3.  All references in this Plan to the Compensation Committee shall mean the Board when (i) there is no Compensation
Committee or (ii) the Board has retained the power to administer this Plan.

 

“Disability” means
“permanent and total disability” as defined in Section 22(e)(3) of the Code or successor statute.

 

“Disqualifying Disposition”
means any disposition (including any sale) of Common Stock underlying an ISO before the later of (i) two years after the date of employee
was granted the ISO or (ii) one year after the date the employee acquired Common Stock by exercising the ISO.

 

“Exchange Act”
shall mean the Securities Exchange Act of 1934.

 

“Fair Market Value”
shall be determined as of the last Trading Day before the date a Stock Right is granted and shall mean:

 

(1)
the closing price on the principal market if the Common Stock is listed on a national securities exchange or the OTCQB or OTCQX.

 

(2)
if the Company’s shares are not listed on a national securities exchange or the OTCQB or OTCQX, then the closing price if reported
or the average bid and asked price for the Company’s shares as published by OTC Markets Group, Inc.;

 

(3)
if there are no prices available under clauses (1) or (2), then Fair Market Value shall be based upon the average closing bid and asked
price as determined following a polling of all dealers making a market in the Company’s Common Stock; or

 

(4)  if
there is no regularly established trading market for the Company’s Common Stock or if the Company’s Common Stock is listed,
quoted or reported under clauses (1) or (2) but it trades sporadically rather than every day, the Fair Market Value shall be established
by the Board or the Compensation Committee taking into consideration all relevant factors including the most recent price at which the
Company’s Common Stock was sold.

 

“ISO” shall have
the meaning given to it in Section 1(a).

 

“Non-Qualified Options”
shall have the meaning given to it in Section 1(a).

 

“Officers” means
a person who is an executive officer of the Company and is required to file ownership reports under Section 16(a) of the Exchange Act.

 

“Options” shall
have the meaning given to it in Section 1(a).

 

    2 

     

    

 

“Plan” shall have
the meaning given to it in Section 1(a).

 

“Related Corporations”
shall mean a corporation which is a subsidiary corporation with respect to the Company within the meaning of Section 424(f) of the Code.

 

“Restricted Stock”
shall have the meaning contained in Section 1(a).

 

“RSU” shall have
the meaning given to it in Section 1(a).

 

“SAR” shall have
the meaning given to it in Section 1(a).

 

“Securities Act”
means the Securities Act of 1933.

 

“Stock Rights”
shall have the meaning given to it in Section 1(a).

 

“Trading Day” shall
mean a day on which The Nasdaq Stock Market LLC is open for business.

 

This Plan is intended to comply
in all respects with Rule 16b-3 (“Rule 16b-3”) and its successor rules as promulgated under Section 16(b) of the Exchange
Act for participants who are subject to Section 16 of the Exchange Act. To the extent any provision of the Plan or action by the Plan
administrators fails to so comply, it shall be deemed null and void to the extent permitted by law and deemed advisable by the Plan administrators. Provided, however,
such exercise of discretion by the Plan administrators shall not interfere with the contract rights of any grantee. In the event that
any interpretation or construction of the Plan is required, it shall be interpreted and construed in order to ensure, to the maximum extent
permissible by law, that such grantee does not violate the short-swing profit provisions of Section 16(b) of the Exchange Act and that
any exemption available under Rule 16b-3 or other rule is available.

 

2. Administration of the
Plan.

 

(a) The Plan may be administered
by the entire Board or by the Compensation Committee. Once appointed, the Compensation Committee shall continue to serve until otherwise
directed by the Board. A majority of the members of the Compensation Committee shall constitute a quorum, and all determinations of the
Compensation Committee shall be made by the majority of its members present at a meeting. Any determination of the Compensation Committee
under the Plan may be made without notice or meeting of the Compensation Committee by a writing signed by all of the Compensation Committee
members. Subject to ratification of the grant of each Stock Right by the Board (but only if so required by applicable state law), and
subject to the terms of the Plan, the Compensation Committee shall have the authority to (i) determine the employees of the Company and
Related Corporations (from among the class of employees eligible under Section 3 to receive ISOs) to whom ISOs may be granted, and to
determine (from among the class of individuals and entities eligible under Section 3 to receive Non-Qualified Options, Restricted Stock,
RSUs and SARs) to whom Non-Qualified Options, Restricted Stock, RSUs and SARs may be granted; (ii) determine when Stock Rights may be
granted; (iii) determine the exercise prices of Stock Rights other than Restricted Stock and RSUs, which shall not be less than the Fair
Market Value; (iv) determine whether each Option granted shall be an ISO or a Non-Qualified Option; (v) determine when Stock Rights shall
become exercisable, the duration of the exercise period and when each Stock Right shall vest; (vi) determine whether restrictions such
as repurchase options are to be imposed on shares subject to or issued in connection with Stock Rights, and the nature of such restrictions,
if any, and (vii) interpret the Plan and promulgate and rescind rules and regulations relating to it. The interpretation and construction
by the Compensation Committee of any provisions of the Plan or of any Stock Right granted under it shall be final, binding and conclusive
unless otherwise determined by the Board. The Compensation Committee may from time to time adopt such rules and regulations for carrying
out the Plan as it may deem best.

 

    3 

     

    

 

No members of the Compensation
Committee or the Board shall be liable for any action or determination made in good faith with respect to the Plan or any Stock Right
granted under it. No member of the Compensation Committee or the Board shall be liable for any act or omission of any other member of
the Compensation Committee or the Board or for any act or omission on his own part, including but not limited to the exercise of any power
and discretion given to him under the Plan, except those resulting from his own gross negligence or willful misconduct.

 

(b) The Compensation Committee
may select one of its members as its chairman and shall hold meetings at such time and places as it may determine. All references in this
Plan to the Compensation Committee shall mean the Board if no Compensation Committee has been appointed. From time to time the Board may
increase the size of the Compensation Committee and appoint additional members thereof, remove members (with or without cause) and appoint
new members in substitution therefor, fill vacancies however caused or remove all members of the Compensation Committee and thereafter
directly administer the Plan.

 

(c) Stock Rights may be granted
to members of the Board, whether such grants are in their capacity as directors, Officers or consultants. All grants of Stock Rights to
members of the Board shall in all other respects be made in accordance with the provisions of this Plan applicable to other eligible persons.
Members of the Board who are either (i) eligible for Stock Rights pursuant to the Plan or (ii) have been granted Stock Rights may vote
on any matters affecting the administration of the Plan or the grant of any Stock Rights pursuant to the Plan.

 

(d) In addition to such other
rights of indemnification as he or she may have as a member of the Board, and with respect to administration of the Plan and the granting
of Stock Rights under it, each member of the Board and of the Compensation Committee shall be entitled without further act on his part
to indemnification from the Company for all expenses (including advances of litigation expenses, the amount of judgment and the amount
of approved settlements made with a view to the curtailment of costs of litigation) reasonably incurred by him in connection with or arising
out of any action, suit or proceeding, including any appeal thereof, with respect to the administration of the Plan or the granting of
Stock Rights under it in which he may be involved by reason of his being or having been a member of the Board or the Compensation Committee,
whether or not he continues to be such member of the Board or the Compensation Committee at the time of the incurring of such expenses; provided, however,
that such indemnity shall be subject to the limitations contained in any Indemnification Agreement between the Company and the Board member
or Officer. The foregoing right of indemnification shall inure to the benefit of the heirs, executors or administrators of each such member
of the Board or the Compensation Committee and shall be in addition to all other rights to which such member of the Board or the Compensation
Committee would be entitled to as a matter of law, contract or otherwise.

 

(e) The Board may delegate
the powers to grant Stock Rights to Officers to the extent permitted by the laws of the Company’s state of incorporation.

 

    4 

     

    

 

3. Eligible Employees and
Others.  ISOs may be granted to any employee of the Company or any Related Corporation. Those Officers and directors of the Company
who are not employees may not be granted ISOs under the Plan. Subject to compliance with Rule 16b-3 and other applicable securities laws,
Non-Qualified Options, Restricted Stock, RSUs and SARs may be granted to any director (whether or not an employee), Officers, employees
or consultants of the Company or any Related Corporation. The Compensation Committee may take into consideration a recipient’s individual
circumstances in determining whether to grant an ISO, a Non-Qualified Option, Restricted Stock, RSUs or a SAR. Granting of any Stock Right
to any individual or entity shall neither entitle that individual or entity to, nor disqualify him from participation in, any other grant
of Stock Rights.

 

4. Common Stock. The
Common Stock subject to Stock Rights shall be authorized but unissued shares of Common Stock, or shares of Common Stock reacquired by
the Company in any manner, including purchase, forfeiture or otherwise. The aggregate number of shares of Common Stock which may be issued
pursuant to the Plan is 5,000,000, less any Stock Rights previously granted or exercised subject to adjustment as provided in Section
14. Any such shares may be issued under ISOs, Non-Qualified Options, Restricted Stock, RSUs or SARs, so long as the number of shares so
issued does not exceed the limitations in this Section. Subject to adjustment in accordance with Section 14, no more than 5,000,000 shares
of Common Stock may be issued in the aggregate pursuant to the exercise of ISOs. If any Stock Rights granted under the Plan shall expire
or terminate for any reason without having been exercised in full or shall cease for any reason to be exercisable in whole or in part,
or if the Company shall reacquire any unvested shares, the unpurchased shares subject to such Stock Rights and any unvested shares so
reacquired by the Company shall again be available for grants under the Plan. For the avoidance of doubt, in the event that (i) the payment
of the exercise price of any Stock Right, or (ii) the satisfaction of any tax withholding obligations arising from any Stock Right is
made by withholding of shares of Common Stock by the Company, the shares so withheld shall again become available for grants under the
Plan.

 

5. Granting of Stock Rights.

 

(a) The date of grant of a
Stock Right under the Plan will be the date specified by the Board or Compensation Committee at the time it grants the Stock Right; provided, however,
that such date shall not be prior to the date on which the Board or Compensation Committee acts to approve the grant. The Board or Compensation
Committee shall have the right, with the consent of the optionee, to convert an ISO granted under the Plan to a Non-Qualified Option pursuant
to Section 17.

 

(b) The Board or Compensation
Committee shall grant Stock Rights to participants that it, in its sole discretion, selects. Stock Rights shall be granted on such terms
as the Board or Compensation Committee shall determine except that ISOs shall be granted on terms that comply with the Code and regulations
thereunder.

 

    5 

     

    

 

(c) A SAR entitles the holder
to receive, as designated by the Board or Compensation Committee, cash or shares of Common Stock, value equal to (or otherwise based on)
the excess of: (a) the Fair Market Value of a specified number of shares of Common Stock at the time of exercise over (b) an exercise
price established by the Board or Compensation Committee. The exercise price of each SAR granted under this Plan shall be established
by the Compensation Committee or shall be determined by a method established by the Board or Compensation Committee at the time the SAR
is granted, provided the exercise price shall not be less than 100% of the Fair Market Value of a share of Common Stock on the date of
the grant of the SAR, or such higher price as is established by the Board or Compensation Committee. A SAR shall be exercisable in accordance
with such terms and conditions and during such periods as may be established by the Board or Compensation Committee. Shares of Common
Stock delivered pursuant to the exercise of a SAR shall be subject to such conditions, restrictions and contingencies as the Board or
Compensation Committee may establish in the applicable SAR agreement or document, if any. The Board or Compensation Committee, in its
discretion, may impose such conditions, restrictions and contingencies with respect to shares of Common Stock acquired pursuant to the
exercise of each SAR as the Board or Compensation Committee determines to be desirable. A SAR under the Plan shall be subject to such
terms and conditions, not inconsistent with the Plan, as the Board or Compensation Committee shall, in its discretion, prescribe. The
terms and conditions of any SAR to any grantee shall be reflected in such form of agreement as is determined by the Board or Compensation
Committee. A copy of such document, if any, shall be provided to the grantee, and the Board or Compensation Committee may condition the
granting of the SAR on the grantee executing such agreement.

 

(d) An RSU gives the grantee
the right to receive a number of shares of the Company’s Common Stock on applicable vesting or other dates. Delivery of the RSUs
may be deferred beyond vesting as determined by the Board or Compensation Committee. RSUs shall be evidenced by an RSU agreement in the
form determined by the Board or Compensation Committee. With respect to an RSU, which becomes non-forfeitable due to the lapse of
time, the Compensation Committee shall prescribe in the RSU agreement the vesting period. With respect to the granting of the RSU, which
becomes non-forfeitable due to the satisfaction of certain pre-established performance-based objectives imposed by the Board or Compensation
Committee, the measurement date of whether such performance-based objectives have been satisfied shall be a date no earlier than the first
anniversary of the date of the RSU. A recipient who is granted an RSU shall possess no incidents of ownership with respect to such underlying
Common Stock, although the RSU agreement may provide for payments in lieu of dividends to such grantee.

 

(e) Notwithstanding any provision
of this Plan, the Board or Compensation Committee may impose conditions and restrictions on any grant of Stock Rights including forfeiture
of vested Options, cancellation of Common Stock acquired in connection with any Stock Right and forfeiture of profits.

 

(f) The Options and SARs shall
not be exercisable for a period of more than 10 years from the date of grant.  

 

6. Sale of Shares. The
shares underlying Stock Rights granted to any Officer, director or a beneficial owner of 10% or more of the Company’s securities
registered under Section 12 of the Exchange Act shall not be sold, assigned or transferred by the grantee until at least six months elapse
from the date of the grant thereof.

 

    6 

     

    

 

7. ISO Minimum Option Price
and Other Limitations.

 

(a) The exercise price per
share relating to all Options granted under the Plan shall not be less than the Fair Market Value per share of Common Stock on the last
trading day prior to the date of such grant. For purposes of determining the exercise price, the date of the grant shall be the later
of (i) the date of approval by the Board or Compensation Committee or the Board, or (ii) for ISOs, the date the recipient becomes an employee
of the Company. In the case of an ISO to be granted to an employee owning Common Stock which represents more than 10% of the total combined
voting power of all classes of stock of the Company or any Related Corporation, the price per share shall not be less than 110% of the
Fair Market Value per share of Common Stock on the date of grant and such ISO shall not be exercisable after the expiration of five years
from the date of grant.

 

(b) In no event shall the aggregate
Fair Market Value (determined at the time an ISO is granted) of Common Stock for which ISOs granted to any employee are exercisable for
the first time by such employee during any calendar year (under all stock option plans of the Company and any Related Corporation) exceed
$100,000.  

 

8. Duration of Stock Rights.
Subject to earlier termination as provided in Sections 5, 9, 10 and 11, each Option and SAR shall expire on the date specified in the
original instrument granting such Stock Right (except with respect to any part of an ISO that is converted into a Non-Qualified Option
pursuant to Section 17), provided, however, that such instrument must comply with Section 422 of the Code with
regard to ISOs and Rule 16b-3 with regard to all Stock Rights granted pursuant to the Plan to Officers, directors and 10% shareholders
of the Company.

 

9. Exercise of Options and
SARs; Vesting of Stock Rights. Subject to the provisions of Sections 9 through 13, each Option and SAR granted under the Plan shall
be exercisable as follows:

 

(a) The Options and SARs shall
either be fully vested and exercisable from the date of grant or shall vest and become exercisable in such installments as the Board or
Compensation Committee may specify.

 

(b) Once an installment becomes
exercisable it shall remain exercisable until expiration or termination of the Option and SAR, unless otherwise specified by the Board
or Compensation Committee.

 

(c) Each Option and SAR or
installment, once it becomes exercisable, may be exercised at any time or from time to time, in whole or in part, for up to the total
number of shares with respect to which it is then exercisable.

 

(d) The Board or Compensation
Committee shall have the right to accelerate the vesting date of any installment of any Stock Right; provided that the
Board or Compensation Committee shall not accelerate the exercise date of any installment of any Option granted to any employee as an
ISO (and not previously converted into a Non-Qualified Option pursuant to Section 17) if such acceleration would violate the annual exercisability
limitation contained in Section 422(d) of the Code as described in Section 7(b).

 

    7 

     

    

 

10. Termination of Employment.
Subject to any greater restrictions or limitations as may be imposed by the Board or Compensation Committee or by a written agreement,
if an optionee ceases to be employed by the Company and all Related Corporations other than by reason of death or Disability, no further
installments of his Options shall vest or become exercisable, and his Options shall terminate as provided for in the grant or on the day
12  months after the day of the termination of his employment (except three months for ISOs), whichever is earlier, but in no event
later than on their specified expiration dates. Employment shall be considered as continuing uninterrupted during any bona fide leave
of absence (such as those attributable to illness, military obligations or governmental service) provided that the period of such leave
does not exceed 90 days or, if longer, any period during which such optionee’s right to re-employment is guaranteed by statute.
A leave of absence with the written approval of the Board shall not be considered an interruption of employment under the Plan, provided
that such written approval contractually obligates the Company or any Related Corporation to continue the employment of the optionee after
the approved period of absence. ISOs granted under the Plan shall not be affected by any change of employment within or among the Company
and Related Corporations so long as the optionee continues to be an employee of the Company or any Related Corporation.

 

11. Death; Disability.
Unless otherwise determined by the Board or Compensation Committee or by a written agreement:

 

(a) If the holder of an Option
or SAR ceases to be employed by the Company and all Related Corporations by reason of his death, any Options or SARs held by the optionee
may be exercised to the extent he could have exercised it on the date of his death, by his estate, personal representative or beneficiary
who has acquired the Options or SARs by will or by the laws of descent and distribution, at any time prior to the earlier of: (i) the
Options’ or SARs’ specified expiration date or (ii) one year (except three months for an ISO) from the date of death.

 

(b) If the holder of an Option
or SAR ceases to be employed by the Company and all Related Corporations, or a director or Director Advisor can no longer perform his
duties, by reason of his Disability, any Options or SARs held by the optionee may be exercised to the extent he could have exercised it
on the date of termination due to Disability until the earlier of (i) the Options’ or SARs’ specified expiration date or (ii)
one year from the date of the termination.

 

12. Assignment, Transfer
or Sale.

 

(a) No ISO granted under this
Plan shall be assignable or transferable by the grantee except by will or by the laws of descent and distribution, and during the lifetime
of the grantee, each ISO shall be exercisable only by him, his guardian or legal representative.

 

(b) Except for ISOs, all Stock
Rights are transferable subject to compliance with applicable securities laws and Section 6 of this Plan.

 

13. Terms and Conditions
of Stock Rights. Stock Rights shall be evidenced by instruments (which need not be identical) in such forms as the Board or Compensation
Committee may from time to time approve. Such instruments shall conform to the terms and conditions set forth in Sections 5 through 12
hereof and may contain such other provisions as the Board or Compensation Committee deems advisable which are not inconsistent with the
Plan. In granting any Stock Rights, the Board or Compensation Committee may specify that Stock Rights shall be subject to the restrictions
set forth herein with respect to ISOs, or to such other termination and cancellation provisions as the Board or Compensation Committee
may determine. The Board or Compensation Committee may from time to time confer authority and responsibility on one or more of its own
members and/or one or more Officers of the Company to execute and deliver such instruments. The proper Officers of the Company are authorized
and directed to take any and all action necessary or advisable from time to time to carry out the terms of such instruments.

 

    8 

     

    

 

14. Adjustments Upon Certain
Events.

 

(a) Subject to any required
action by the shareholders of the Company, the number of shares of Common Stock covered by each outstanding Stock Right, and the number
of shares of Common Stock which have been authorized for issuance under the Plan but as to which no Stock Rights have yet been granted
or which have been returned to the Plan upon cancellation or expiration of a Stock Right, as well as the price per share of Common Stock
(or cash, as applicable) covered by each such outstanding Option or SAR, shall be proportionately adjusted for any increases or decrease
in the number of issued shares of Common Stock resulting from a stock split, reverse stock split, stock dividend, combination or reclassification
of Common Stock, or any other increase or decrease in the number of issued shares of Common Stock effected without receipt of consideration
by the Company; provided, however, that conversion of any convertible securities of the Company or the voluntary
cancellation whether by virtue of a cashless exercise of a derivative security of the Company or otherwise shall not be deemed to have
been “effected without receipt of consideration.”  Such adjustment shall be made by the Board or Compensation Committee,
whose determination in that respect shall be final, binding and conclusive.  Except as expressly provided herein, no issuance by
the Company of shares of stock of any class, or securities convertible into shares of stock of any class, shall affect, and no adjustment
by reason thereof shall be made with respect to, the number or price of shares of Common Stock subject to a Stock Right. No adjustments
shall be made for dividends or other distributions paid in cash or in property other than securities of the Company.

 

(b) In the event of the proposed
dissolution or liquidation of the Company, the Board or Compensation Committee shall notify each participant as soon as practicable prior
to the effective date of such proposed transaction.  To the extent it has not been previously exercised, a Stock Right will terminate
immediately prior to the consummation of such proposed action.

 

(c) In the event of a merger
of the Company with or into another corporation, or a Change of Control, each outstanding Stock Right shall be assumed (as defined below)
or an equivalent option or right substituted by the successor corporation or a parent or subsidiary of the successor corporation. 
In the event that the successor corporation refuses to assume or substitute for the Stock Rights, the participants shall fully vest in
and have the right to exercise their Stock Rights as to which it would not otherwise be vested or exercisable.  If a Stock Right
becomes fully vested and exercisable in lieu of assumption or substitution in the event of a merger or sale of assets, the Board or Compensation
Committee shall notify the participant in writing or electronically that the Stock Right shall be fully vested and exercisable for a period
of at least 15 days from the date of such notice, and any Options or SARs shall terminate one minute prior to the closing of the merger
or sale of assets.   

 

    9 

     

    

 

For the purposes of this Section
14(c), the Stock Right shall be considered “assumed” if, following the merger or Change of Control, the option or right confers
the right to purchase or receive, for each share of Common Stock subject to the Stock Right immediately prior to the merger or Change
of Control, the consideration (whether stock, cash, or other securities or property) received in the merger or Change of Control by holders
of Common Stock for each share held on the effective date of the transaction (and if holders were offered a choice of consideration, the
type of consideration chosen by the holders of a majority of the outstanding Shares); provided, however, that
if such consideration received in the merger or Change of Control is not solely common stock of the successor corporation or its parent,
the Board or Compensation Committee may, with the consent of the successor corporation, provide for the consideration to be received upon
the exercise of the Stock Right, for each share of Common Stock subject to the Stock Right, to be solely common stock of the successor
corporation or its parent equal in Fair Market Value to the per share consideration received by holders of Common Stock in the merger
or Change of Control.

 

(d) Notwithstanding the foregoing,
any adjustments made pursuant to Section 14(a), (b) or (c) with respect to ISOs shall be made only after the Board or Compensation Committee,
after consulting with counsel for the Company, determines whether such adjustments would constitute a “modification” of such
ISOs (as that term is defined in Section 424(h) of the Code) or would cause any adverse tax consequences for the holders of such ISOs.
 If the Board or Compensation Committee determines that such adjustments made with respect to ISOs would constitute a modification
of such ISOs it may refrain from making such adjustments.

 

(e) No fractional shares shall
be issued under the Plan and the optionee shall receive from the Company cash in lieu of such fractional shares.

 

15. Means of Exercising
Stock Rights.

 

(a) An Option or SAR (or any
part or installment thereof) shall be exercised by giving written notice to the Company at its principal office address. Such notice shall
identify the Stock Right being exercised and specify the number of shares as to which such Stock Right is being exercised, accompanied
by full payment of the exercise price therefor (to the extent it is exercisable in cash) either (i) in United States dollars by check
or wire transfer; or (ii) at the discretion of the Board or Compensation Committee, through delivery of shares of Common Stock having
a Fair Market Value equal as of the date of the exercise to the cash exercise price of the Stock Right or such other formula as may be
approved by the Board or Compensation Committee; or (iii) at the discretion of the Board or Compensation Committee, by any combination
of (i) and (ii) above. If the Board or Compensation Committee exercises its discretion to permit payment of the exercise price of an ISO
by means of the methods set forth in clauses (ii) or (iii) of the preceding sentence, such discretion need not be exercised in writing
at the time of the grant of the Stock Right in question. The holder of a Stock Right shall not have the rights of a shareholder with respect
to the shares covered by his Stock Right until the date of issuance of a stock certificate to him for such shares. Except as expressly
provided above in Section 14 with respect to changes in capitalization and stock dividends, no adjustment shall be made for dividends
or similar rights for which the record date is before the date such stock certificate is issued.

 

    10 

     

    

 

(b) Each notice of exercise
shall, unless the shares of Common Stock are covered by a then current registration statement under the Securities Act, contain the holder’s
acknowledgment in form and substance satisfactory to the Company that (i) such shares are being purchased for investment and not for distribution
or resale (other than a distribution or resale which, in the opinion of counsel satisfactory to the Company, may be made without violating
the registration provisions of the Securities Act), (ii) the holder has been advised and understands that (1) the shares have not been
registered under the Securities Act and are “restricted securities” within the meaning of Rule 144 under the Securities Act
and are subject to restrictions on transfer and (2) the Company is under no obligation to register the shares under the Securities Act
or to take any action which would make available to the holder any exemption from such registration, and (iii) such shares may not be
transferred without compliance with all applicable federal and state securities laws. Notwithstanding the above, should the Company be
advised by counsel that issuance of shares should be delayed pending registration under federal or state securities laws or the receipt
of an opinion that an appropriate exemption therefrom is available, the Company may defer exercise of any Stock Right granted hereunder
until either such event has occurred.

 

16. Term, Termination and
Amendment.  

 

(a) This Plan was adopted by
the Board.  This Plan may be approved by the Company’s shareholders, which approval is required for ISOs.

 

(b) The Board may terminate
the Plan at any time.  Unless sooner terminated, the Plan shall terminate on September 6, 2028 or 10 years from the date the Board
adopts the Plan. No Stock Rights may be granted under the Plan once the Plan is terminated.  Termination of the Plan shall
not impair rights and obligations under any Stock Right granted while the Plan is in effect, except with the written consent of the grantee.

 

(c) The Board at any time,
and from time to time, may amend the Plan.  Provided, however, except as provided in Section 14 relating to adjustments
in Common Stock, no amendment shall be effective unless approved by the shareholders of the Company to the extent (i) shareholder approval
is necessary to satisfy the requirements of Section 422 of the Code or (ii) required by the rules of the principal national securities
exchange or trading market upon which the Company’s Common Stock trades. Rights under any Stock Rights granted before amendment
of the Plan shall not be impaired by any amendment of the Plan, except with the written consent of the grantee.

 

(d) The Board at any time,
and from time to time, may amend the terms of any one or more Stock Rights; provided, however, that the rights
under the Stock Right shall not be impaired by any such amendment, except with the written consent of the grantee.

 

17. Conversion of ISOs into
Non-Qualified Options; Termination of ISOs. The Board or Compensation Committee, at the written request of any optionee, may in its
discretion take such actions as may be necessary to convert such optionee’s ISOs (or any installments or portions of installments
thereof) that have not been exercised on the date of conversion into Non-Qualified Options at any time prior to the expiration of such
ISOs, regardless of whether the optionee is an employee of the Company or a Related Corporation at the time of such conversion.  Provided, however,
the Board or Compensation Committee shall not reprice the Options or extend the exercise period or reduce the exercise price of the appropriate
installments of such Options without the approval of the Company’s shareholders. At the time of such conversion, the Board or Compensation
Committee (with the consent of the optionee) may impose such conditions on the exercise of the resulting Non-Qualified Options as the
Board or Compensation Committee in its discretion may determine, provided that such conditions shall not be inconsistent with this Plan.
Nothing in the Plan shall be deemed to give any optionee the right to have such optionee’s ISOs converted into Non-Qualified Options,
and no such conversion shall occur until and unless the Board or Compensation Committee takes appropriate action. The Compensation Committee,
with the consent of the optionee, may also terminate any portion of any ISO that has not been exercised at the time of such termination.

 

    11 

     

    

 

18. Application of Funds.
The proceeds received by the Company from the sale of shares pursuant to Options or SARS (if cash settled) granted under the Plan shall
be used for general corporate purposes.

 

19. Governmental Regulations.
The Company’s obligation to sell and deliver shares of the Common Stock under this Plan is subject to the approval of any governmental
authority required in connection with the authorization, issuance or sale of such shares.

 

20. Withholding of Additional
Income Taxes. In connection with the granting, exercise or vesting of a Stock Right or the making of a Disqualifying Disposition the
Company, in accordance with Section 3402(a) of the Code, may require the optionee to pay additional withholding taxes in respect of the
amount that is considered compensation includable in such person’s gross income.

 

To the extent that the Company is required to
withhold taxes for federal income tax purposes as provided above, if any optionee may elect to satisfy such withholding requirement by
(i) paying the amount of the required withholding tax to the Company; (ii) delivering to the Company shares of its Common Stock (including
shares of Restricted Stock) previously owned by the optionee; or (iii) having the Company retain a portion of the shares covered by an
Option exercise. The number of shares to be delivered to or withheld by the Company times the Fair Market Value of such shares or such
other formula as may be approved by the Board or Compensation Committee pursuant to the Plan shall equal the cash required to be withheld.

 

21. Notice to the Company
of Disqualifying Disposition. Each employee who receives an ISO must agree to notify the Company in writing immediately after the
employee makes a Disqualifying Disposition of any Common Stock acquired pursuant to the exercise of an ISO. If the employee has died before
such stock is sold, the holding periods requirements of the Disqualifying Disposition do not apply and no Disqualifying Disposition can
occur thereafter.

 

22. Continued Employment.
The grant of a Stock Right pursuant to the Plan shall not be construed to imply or to constitute evidence of any agreement, express or
implied, on the part of the Company or any Related Corporation to retain the grantee in the employ of the Company or a Related Corporation,
as a member of the Company’s Board or in any other capacity, whichever the case may be.

 

23. Governing Law; Construction.
The validity and construction of the Plan and the instruments evidencing Stock Rights shall be governed by the laws of the Company’s
state of incorporation. In construing this Plan, the singular shall include the plural and the masculine gender shall include the feminine
and neuter, unless the context otherwise requires.

 

    12 

     

    

 

24. (a) Forfeiture of Stock
Rights Granted to Employees or Consultants. Notwithstanding any other provision of this Plan, and unless otherwise provided for in
a Stock Rights Agreement, all vested or unvested Stock Rights granted to employees or consultants shall be immediately forfeited at the
discretion of the Board if any of the following events occur:

 

(1) Termination of the relationship
with the grantee for cause including, but not limited to, fraud, theft, dishonesty and violation of Company policy;

 

(2) Purchasing or selling
securities of the Company in violation of the Company’s insider trading guidelines then in effect;

 

(3) Breaching any duty of
confidentiality including that required by the Company’s insider trading guidelines then in effect;

 

(4) Competing with the Company;

 

(5) Being unavailable for
consultation after leaving the Company’s employment if such availability is a condition of any agreement between the Company and
the grantee;

 

(6) Recruitment of Company
personnel after termination of employment, whether such termination is voluntary or for cause;

 

(7) Failure to assign any
invention or technology to the Company if such assignment is a condition of employment or any other agreements between the Company and
the grantee; or

 

(8) A finding by the Board
that the grantee has acted disloyally and/or against the interests of the Company.

 

(b) Forfeiture of Stock
Rights Granted to Directors.  Notwithstanding any other provision of this Plan, and unless otherwise provided for in a Stock
Rights Agreement, all vested or unvested Stock Rights granted to directors shall be immediately forfeited at the discretion of the Board
if any of the following events occur:

 

(1) Purchasing or selling
securities of the Company in violation of the Company’s insider trading guidelines then in effect;

 

(2) Breaching any duty of
confidentiality including that required by the Company’s insider trading guidelines then in effect;

 

(3) Competing with the Company;

 

(4) Recruitment of Company
personnel after ceasing to be a director;

or

 

(5) A finding by the Board
that the grantee has acted disloyally and/or against the interests of the Company.

 

The Company may impose other
forfeiture restrictions which are more or less restrictive and require a return of profits from the sale of Common Stock as part of said
forfeiture provisions if such forfeiture provisions and/or return of provisions are contained in a Stock Rights Agreement.

 

(c) Profits on the Sale
of Certain Shares; Redemption.  If any of the events specified in Section 24(a) or (b) of the Plan occur within one year from
the date the grantee last performed services for the Company in the capacity for which the Stock Rights were granted (the  “Termination
Date”) (or such longer period required by any written agreement), all profits earned from the sale of the Company’s securities,
including the sale of shares of Common Stock underlying the Stock Rights, during the two-year period commencing one year prior to the
Termination Date shall be forfeited and immediately paid by the grantee to the Company.  Further, in such event, the Company may
at its option redeem shares of Common Stock acquired upon exercise of the Stock Right by payment of the exercise price to the grantee.
 To the extent that another written agreement with the Company extends the events in Section 24(a) or (b) beyond one year following
the Termination Date, the two-year period shall be extended by an equal number of days.  The Company’s rights under this Section
24(c) do not lapse one year form the Termination Date but are contract rights subject to any appropriate statutory limitation period.

 

 

 

13Exhibit 10.2

 

 

 

EMPLOYMENT AGREEMENT

 

THIS EMPLOYMENT
AGREEMENT (the “Agreement”) is entered into as of October 1, 2021 (the “Effective Date”), between Agora Digital
Holdings, Inc., a Nevada corporation (“Agora” or the “Company”), and William Hoagland (the “Executive”).

 

WHEREAS, in its business,
the Company has acquired and developed certain trade secrets, including, but not limited to, proprietary processes, sales methods and
techniques, and other like confidential business and technical information, including but not limited to, technical information, design
systems, pricing methods, pricing rates or discounts, processes, procedures, formulas, designs of computer software, or improvements,
or any portion or phase thereof, whether patented, or not, or unpatentable, that is of any value whatsoever to the Company, as well as
information relating to the Company’s Services (as defined below), information concerning proposed new Services, market feasibility
studies, proposed or existing marketing techniques or plans (whether developed or produced by the Company or by any other person or entity
for the Company), other Confidential Information (as defined below), and information about the Company’s executives, officers, and
directors, which necessarily will be communicated to the Executive by reason of his employment by the Company; and

 

WHEREAS, the
Company has strong and legitimate business interests in preserving and protecting its investment in the Executive, its trade secrets and
Confidential Information, and its substantial, significant, or key, relationships with vendors, and, each, as defined below, whether actual
or prospective; and

 

WHEREAS, the
Company desires to preserve and protect its legitimate business interests further by restricting competitive activities of the Executive
during the term of this Agreement and for a reasonable time following the termination of this Agreement; and

 

WHEREAS, the Company
desires to continue to employ the Executive and to ensure the continued availability to the Company of the Executive’s services,
and the Executive is willing to accept such employment and render such services, all upon and subject to the terms and conditions contained
in this Agreement.

 

NOW, THEREFORE,
in consideration of the premises and the mutual covenants set forth in this Agreement, and intending to be legally bound, the Company
and the Executive agree as follows:

 

1.
Representations and Warranties. The Executive hereby represents and warrants to the Company that he (i) is not subject to any non-solicitation
or non-competition agreement affecting his employment with the Company (other than any prior agreement with the Company or its affiliates),
(ii) is not subject to any confidentiality or nonuse/nondisclosure agreement affecting his employment with the Company (other than any
prior agreement with the Company or its affiliates), and (iii) has brought to the Company no trade secrets, confidential business information,
documents, or other personal property of a prior employer, except with respect to Ecoark Holdings, Inc. (“ZEST”).

 

    

     

    

 

2.
Term of Employment.

 

(a)
Term. The Company hereby employs the Executive, and the Executive hereby accepts employment with the Company for a period of three
years commencing as of the Effective Date (such period, as it may be extended or renewed, the “Term”), unless sooner terminated
in accordance with the provisions of Section 6. The Term shall be automatically renewed for successive one-year terms unless notice of
non-renewal is given by either party at least 30 days before the end of the Term.

 

(b)
Continuing Effect. Notwithstanding any termination of this Agreement, at the end of the Term or otherwise, the provisions of Sections
6(e), 7, 8, 9, 10, 12 15, 18, 19, and 22 shall remain in full force and effect and the provisions of Section 9 shall be binding upon the
legal representatives, successors and assigns of the Executive.

 

3.
Duties.

 

(a) General Duties. The Executive shall serve as the Chief Executive Officer (“CEO”) of the Company, with duties and responsibilities
that are customary for such an executive. The Executive shall report to the Company’s Executive Chairman of the Board of Directors
(the “Executive Chairman”). The Executive shall also perform services for such subsidiaries of the Company as may be necessary.
The Executive shall use his best efforts to perform his duties and discharge his responsibilities pursuant to this Agreement competently,
carefully and faithfully. In determining whether or not the Executive has used his best efforts hereunder, the Executive’s and the
Company’s delegation of authority and all surrounding circumstances shall be taken into account and the best efforts of the Executive
shall not be judged solely on the Company’s earnings or other results of the Executive’s performance, except as specifically
provided to the contrary by this Agreement. The Executive shall, if requested, also serve as a member of the Board of the Company or as
an officer or director of any affiliates of the Company for no additional compensation, except with respect to any Employment Agreement
with ZEST.

 

(b) 
Devotion of Time. Subject to Section 3(a) and the last sentence of this Section 3(b), the Executive shall devote such time,
attention and energies to the affairs of the Company and its subsidiaries and affiliates as are necessary to perform his duties and
responsibilities pursuant to this Agreement. The Executive shall not enter the employ of or serve as a consultant to, or in any way
perform any services with or without compensation to, any other persons, business, or organization, without the prior consent of the
Board. Notwithstanding the above, the Executive shall be permitted to devote a limited amount of his time, to professional,
charitable or similar organizations, including, but not limited to, serving as a non-executive director or committee member or as an
advisor to a board of directors or committee of any company or organization provided that such activities do not interfere with the
Executive’s performance of his duties and responsibilities as provided hereunder. Pending the closing of the Company’s
initial public offer (“IPO”), the Executive shall continue his employment with ZEST which shall pay the Executive the
compensation required under any Employment Agreement between ZEST and the Executive (the “ZEST Agreement”). Following
the closing of the IPO, the Executive shall resign his employment and all positions with ZEST. The Executive may also be required to
perform transitional services as an advisor to ZEST after the IPO.

 

(c)
Location of Office. metropolitan Charleston, South Carolina. necessary business travel. The Executive’s principal business
office shall be in However, the Executive’s duties shall include all

 

(d)
Adherence to Inside Information Policies. The Executive acknowledges that the Company will be publicly-held and, as a result, the
Company will implement inside information policies designed to preclude its executive officers and those of its subsidiaries from violating
the federal securities laws by trading on material, non-public information or passing such information on to others in breach of any duty
owed to the Company, or any third party. The Executive will abide by the Company’s inside information policies as they are adopted
and modified, and shall promote these policies internally and promptly execute any agreements generally distributed by the Company to
its employees requiring such employees to abide by these policies.

 

    2

     

    

 

4.
Compensation and Expenses.

 

(a)  
Salary. For the services of the Executive to be rendered under this Agreement, the Company shall pay the Executive an annual
salary of $370,000.00 (the “Base Salary”), less such deductions as shall be required to be withheld by applicable law and
regulations payable in accordance with the Company’s customary payroll practices. The Executive’s Base Salary shall be reviewed
at least annually by the Board and the Board may, but shall not be required to, increase the Base Salary during the Term. However, the
Executive’s Base Salary may not be decreased during the Term. As provided in Section 3(b), Agora shall pay any additional compensation
owed under this Agreement. ZEST shall continue to be responsible for the Executive’s compensation under the ZEST Agreement through
the closing of Agora’s IPO.

 

(b)
Target Bonus. In addition to the Annual Base Salary, the Executive shall be eligible to earn, for each completed 12 month period
following the Effective Date of this Agreement during the Term, an annual bonus (the “Annual Bonus”) of up to 100% of the
Executive’s Annual Base Salary based on terms and conditions, including the financial performance of the Company as well as individual
performance goals, as set forth in a bonus plan that is to be established, approved, administered and determined in all respects in the
sole discretion of the Board or, if applicable, the Board’s Compensation Committee.

 

(c)  
Expenses. In addition to any compensation received pursuant to this Section 4, the Company will reimburse or advance funds to the
Executive for all reasonable documented travel (including travel expenses incurred by the Executive related to his travel to the Company’s
offices), entertainment and miscellaneous expenses incurred in connection with the performance of his duties under this Agreement, provided
that the Executive properly provides a written accounting of such expenses to the Company in accordance with the Company’s practices.
Such reimbursement or advances will be made in accordance with policies and procedures of the Company in effect from time to time relating
to reimbursement of, or advances to, its executive officers.

 

(d)
Equity Grant. Under the 2021 Equity Incentive Plan (the “Plan”), the Executive shall receive a grant of 1,000,000 shares
of restricted common stock (the “Stock Grant”) of the Company granted as of the Effective Date of this Agreement (the “Grant
Date”). As a condition of the grant, the Executive shall execute the Company’s Restricted Stock Agreement. The Stock Grant
will be valued as of the Grant Date based on a methodology and guidance as discussed with the Company’s external tax counsel. The
Executive shall have the ability to assign the Stock Grant to entity of his choice, so long that the entity is subject to the same requirements
by the Securities and Exchange Commission (the “SEC”) for changes in beneficial ownership reporting and disclosure.

 

The Stock Grant shall vest in 3 equal increments based on the following
terms and conditions:

 

		(i)	33.33% or 333,334 shares shall vest on the 1-year anniversary of the Effective Date of this Agreement;

 

		(ii)	33.33% or 333,333 shares shall vest upon the Company’s subsidiary, Bitstream Mining LLC (“Bitstream”)
successfully deploying at least a 20-megawatt (“MW”) power contract in the State of Texas; and

 

		(iii)	33.33% or 333,333 shares shall vest upon Bitstream successfully deploying at least a 40-megawatt (“MW”)
power contract in the State of Texas.

 

5.
Benefits.

 

(a)
Paid Time Off. For each 12-month period during the Term, the Executive shall be entitled to 4 weeks of Paid Time Off without loss
of compensation or other benefits to which he is entitled under this Agreement, to be taken at such times as the Executive may select
and the affairs of the Company may permit. Any unused days will not be carried over to the next 12 month period. Accrued but unused paid
time off during the current calendar year with a separation event shall be paid at the Executive’s base rate of pay when used or
upon termination of employment.

 

    3

     

    

 

(b)
Fringe Benefit and Perquisites. During the Term, the Executive shall be entitled to fringe benefits and perquisites consistent
with the practices of the Company, and to the extent the Company provides similar benefits or perquisites (or both) to similarly situated
executives of the Company.

 

(c)  
Employee Benefits. During the Term, the Executive shall be entitled to participate in all employee benefit plans, practices and
programs maintained by the Company, as in effect from time to time (collectively, “Employee Benefit Plans”), on a basis which
is no less favorable than is provided to other similarly situated executives of the Company, to the extent consistent with applicable
law and the terms of the applicable Employee Benefit Plans. The Company reserves the right to amend or cancel any Employee Benefit Plans
at any time in its sole discretion, subject to the terms of such Employee Benefit Plan and applicable law. Notwithstanding the foregoing,
during the Term, the Company shall provide the Executive with health insurance covering the Executive and family dependents.

 

6.
Termination.

 

(a)  
Death or Disability. Except as otherwise provided in this Agreement, this Agreement shall automatically terminate upon the death
or disability of the Executive. For purposes of this Section 6(a), “disability” shall mean (i) the Executive is unable to
engage in his customary duties by reason of any medically determinable physical or mental impairment that can be expected to result in
death, or last for a continuous period of not less than 12 months; (ii) the Executive is, by reason of any medically determinable physical
or mental impairment that can be expected to result in death, or last for a continuous period of not less than 12 months, receiving income
replacement benefits for a period of not less than three months under an accident and health plan covering employees of the Company; or
(iii) the Executive is determined to be totally disabled by the Social Security Administration. Any question as to the existence of a
disability shall be determined by the written opinion of the Executive’s regularly attending physician (or his guardian) (or the
Social Security Administration, where applicable). In the event that the Executive’s employment is terminated by reason of Executive’s
death or disability, the Company shall pay the following to the Executive or his personal representative: (i) any accrued but unpaid Base
Salary for services rendered to the date of termination, (ii) accrued but unpaid expenses required to be reimbursed under this Agreement,
(iii) any earned but unpaid bonuses for any prior period and his annual bonus prorated to date of termination (to the extent the Compensation
Committee has set a formula and it can be calculated), and (v) all equity awards previously granted to the Executive under the Plan or
similar plan shall thereupon become fully vested, and the Executive or his legally appointed guardian, as the case may be, shall have
up to two years from the date of termination to exercise all such previously granted options, provided that in no event shall any option
be exercisable beyond its term. The Executive (or his estate) shall receive the payments provided herein at such times as he would have
received them if there was no death or disability. Additionally, if the Executive’s employment is terminated because of disability,
any benefits (except perquisites) to which the Executive may be entitled pursuant to Section 5(b) hereof shall continue to be paid or
provided by the Company, as the case may be, for one year, subject to the terms of any applicable plan or insurance contract and applicable
law, provided that such benefits are exempt from Section 409A of the Code by reason of Treasury Regulation 1.409A-1(a)(5) or otherwise.
In the event all or a portion of the benefits to which the Executive was entitled pursuant to Section 5(b) hereof are subject to 409A
of the Code, the Executive shall not be entitled to the benefits that are subject to Section 409A of the Code subsequent to the “applicable
21⁄2 month period” (as such term is defined under Treasury Regulation Section 1.409A-1(b)(4)(i)(A)).

 

(b)
  Termination by the Company for Cause or by the Executive Without Good Reason. The Company may terminate the
Executive’s employment pursuant to the terms of this Agreement at any time for Cause (as defined below) by giving the
Executive written notice of termination. Such termination shall become effective upon the giving of such notice. Upon any such
termination for Cause, or in the event the Executive terminates his employment with the Company without Good Reason (as defined in
Section 6(c)), then the Executive shall have no right to compensation, or reimbursement under Section 4, or to participate in any
Executive benefit programs under Section 5, except as may otherwise be provided for by law, for any period subsequent to the
effective date of termination. For purposes of this Agreement, “Cause” shall mean: (i) the Executive is convicted of, or
pleads guilty or nolo contendere to, a felony related to the business of the Company; (ii) the Executive, in carrying out his duties
hereunder, has acted with gross negligence or intentional misconduct resulting, in any case, in material harm to the Company; (iii)
the Executive misappropriates Company funds or otherwise defrauds the Company including a material amount of money or property;
(iv) the Executive breaches his fiduciary duty to the Company resulting in material profit to him, directly or indirectly; (v) the Executive
materially breaches any agreement with the Company and fails to cure such breach within 10 days of receipt of notice, unless the act is
incapable of being cured; (vi) the Executive breaches any provision of Section 8 or Section 9; (vii) the Executive becomes subject to
a preliminary or permanent injunction issued by a United States District Court enjoining the Executive from violating any securities law
administered or regulated by the SEC; (viii) the Executive becomes subject to a cease and desist order or other order issued by the SEC
after an opportunity for a hearing; (ix) the Executive refuses to carry out a resolution adopted by the Company’s Board at a meeting
in which the Executive was offered a reasonable opportunity to argue that the resolution should not be adopted; or (x) the Executive abuses
alcohol or drugs in a manner that interferes with the successful performance of his duties.

  

    4

     

    

 

(c)
Termination by the Company Without Cause, Termination by Executive for Good Reason or Automatic Termination Upon a Change of Control
or at the end of a Term after the Company provides notice of Non-Renewal.

 

(1)  This
Agreement may be terminated: (i) by the Executive for Good Reason (as defined below), (ii) by the Company without Cause, (iii) upon
any Change of Control event in either Agora or Bitstream as defined in Treasury Regulation Section 1.409A-3(i)(5) provided, that,
within 12 months of the Change of Control event (A) the Company terminates the Executive’s employment, fails to obtain an
agreement from any successor to the Company to assume and agree to perform this Agreement in the same manner and to the same extent
that the Company would be required to perform if no succession had taken place, or changes his title or duties, or (B) the Executive
terminates his employment or (iv) at the end of a Term after the Company provides the Executive with a formal notice in writing of
non-renewal.

 

(2) In the event this Agreement is terminated
by the Executive for Good Reason or by the Company without Cause, the Executive shall be entitled to the following:

 

(A)
any accrued but unpaid Base Salary for services rendered to the date of termination;

 

(B) any accrued
but unpaid expenses required to be reimbursed under this Agreement;

 

(C)
a severance payment (“Severance Amount”) equal to 12 months of the then Base Salary;

 

(D)
the Executive or his legally appointed guardian, as the case may be, shall have up to one year from the date of termination to exercise
all such previously granted options, provided that in no event shall any option be exercisable beyond its Term;

 

(E)
all equity awards previously granted to the Executive under the Plan or similar plan shall thereupon become fully vested; and

 

(F) any
benefits (except perquisites) to which the Executive was entitled pursuant to Section 5(b) hereof shall continue to be paid or
provided by the Company, as the case may be, for six months, subject to the terms of any applicable plan or insurance contract and
applicable law provided that such benefits are exempt from Section 409A of the Code by reason of Treasury Regulation 1.409A-1(a)(5)
or otherwise. In the event all or a portion of the benefits to which the Executive was entitled pursuant to Section 5(b) hereof are
subject to 409A of the Code, the Executive shall not be entitled to the benefits that are subject to Section 409A of the Code
subsequent to the “applicable 2 1⁄2 month period” (as such term is defined under Treasury Regulation Section
1.409A-1(b)(4)(i)(A)).

 

(3)  
In the event of a Change of Control during the Term, the Executive, subject to the termination of employment or change in title as outlined
in Section 6(c)(1), shall be entitled to receive each of the provisions of Section 6(c)(2)(A) – (F) above except that (i) the Severance
Amount shall equal to 18 months of the then Base Salary; (ii) the Executive shall receive 100% of the existing Target Bonus, if any, for
that fiscal year; and (iii) the benefits under Section 6(c)(2)(F) shall continue for an 18 month period provided that such benefits are
exempt from Section 409A of the Code by reason of Treasury Regulation 1.409A-1(a)(5) or otherwise. In the event all or a portion of the
benefits under Section 6(c)(2)(F) are subject to 409A of the Code, the Executive shall not be entitled to the benefits that are subject
to Section 409A of the Code subsequent to the “applicable 2 1⁄2 month period” (as such term is defined under Treasury
Regulation Section 1.409A-1(b)(4)(i)(A)).

 

    5

     

    

 

(4)  
In the event this Agreement is terminated at the end of a Term after the Company provides the Executive with notice of non-renewal and
the Executive remains employed until the end of the Term, the Executive shall be entitled to the following:

 

(A)
any accrued but unpaid Base Salary for services rendered to the date of termination;

 

(B)
any accrued but unpaid expenses required to be reimbursed under this Agreement;

 

(C)
a Severance Amount equal to six months of the then Base Salary;

 

(D)
all equity awards previously granted to the Executive under the Company’s Plan or similar plan shall become fully vested;

 

(E)
the Executive or his legally appointed guardian, as the case may be, shall have up to two years from the date of termination to exercise
all such previously granted options, provided that in no event shall any option be exercisable beyond its Term; and

 

(F)   any benefits
(except perquisites) to which the Executive was entitled pursuant to Section 5(b) hereof shall continue to be paid or provided by the
Company, as the case may be, for six months, subject to the terms of any applicable plan or insurance contract and applicable law provided
that such benefits are exempt from Section 409A of the Code by reason of Treasury Regulation 1.409A-1(a)(5) or otherwise. In the event
all or a portion of the benefits to which the Executive was entitled pursuant to Section 5(b) hereof are subject to 409A of the Code,
the Executive shall not be entitled to the benefits that are subject to Section 409A of the Code subsequent to the “applicable
2 1⁄2 month period” (as such term is defined under Treasury Regulation Section 1.409A-1(b)(4)(i)(A)).

  

Provided, however, that the
Executive shall only be entitled to receive each of the provisions of this Section 6(c)(4)(A)-(F) if the Executive is willing and able
(i) to execute a new agreement providing terms and conditions substantially similar to those in this Agreement and (ii) to continue providing
such services, and therefore, the Company’s non-renewal of the Term will be considered an “involuntary separation from service”
within the meaning of Treasury Regulation Section 1.409A-1(n).

 

(5)  
In the event of a termination for Good Reason, without Cause, or non-renewal by the Company, the payment of the Severance Amount
shall be made at the same times as the Company pays compensation to its employees over the applicable monthly period and any other payments
owed under Section 6(c) shall be promptly paid. Provided, however, that any balance of the Severance Amount remaining due on the
“applicable 21⁄2 month period” (as such term is defined under Treasury Regulation Section 1.409A-1(b)(4)(i)(A)) after
the end of the tax year in which the Executive’s employment is terminated or the Term ends shall be paid on the last day of the
applicable 21⁄2 month period. The payment of the Severance Amount and the acceleration of vesting shall be conditioned on the Executive
signing an Agreement and General Release (in the form which is attached as Exhibit A) which releases the Company or any of its
affiliates (including its officers, directors and their affiliates) from any liability under this Agreement or related to the Executive’s
employment with the Company provided that (x) the payment of the Severance Amount is made on or before the 90th day following the Executive’s
termination of employment; (y) such Agreement and General Release is executed by the Executive, submitted to the Company, and the statutory
period during which the Executive is entitled to revoke the Agreement and General Release under applicable law has expired on or before
that 90th day; and (z) in the event that the 90 day period begins in one taxable year and ends in a second taxable year, then the payment
of the Severance Amount shall be made in the second taxable year. Upon any Change of Control event, all payments owed under Section 6(c)(3)
shall be paid immediately.

 

(d)
Any termination made by the Company under this Agreement shall be approved by the Board.

 

    6

     

    

 

(e)   Upon
(1) voluntary or involuntary termination of the Executive’s employment or (2) the Company’s request at any time during the
Executive’s employment (provided it does not interfere with his ability to perform his duties and responsibilities hereunder), the Executive
shall (i) provide or return to the Company any and all Company property, including keys, key cards, access cards, security devices, employer
credit cards, network access devices, computers, cell phones, smartphones, manuals, work product, thumb drives or other removable information
storage devices, and hard drives, and all Company documents and materials belonging to the Company and stored in any fashion, including
but not limited to those that constitute or contain any Confidential Information or work product, that are in the possession or control
of the Executive, whether they were provided to the Executive by the Company or any of its business associates or created by the Executive
in connection with his employment by the Company; and (ii) delete or destroy all copies of any such documents and materials
not returned to the Company that remain in the Executive’s possession or control, including those stored on any non-Company devices,
networks, storage locations and media in the Executive’s possession or control.

 

 

7.
Indemnification. As provided in an Indemnification Agreement which the Company and the Executive have previously entered into,
a copy of which is annexed as Exhibit B, the Company shall indemnify the Executive, to the maximum extent permitted by applicable
law, against all costs, charges and expenses incurred or sustained by him in connection with any claim, action, suit or proceeding to
which he may be made a party by reason of him being an officer, director or employee of the Company or of any subsidiary or affiliate
of the Company. The Company shall provide, at its expense, directors and officers insurance for the Executive in amounts and for a term
consistent with industry standards.

 

8.
Non-Competition Agreement.

 

(a)
Competition with the Company. Until termination of his employment and for a period of one year commencing on the date of termination,
the Executive (individually or in association with, or as a shareholder, director, officer, consultant, employee, partner, joint venturer,
manager, member, or otherwise, of or through any person, firm, corporation, partnership, limited liability company, association or other
entity) shall not, directly or indirectly, act as an employee or officer (or comparable position) of, owning an interest in, or providing
Services as defined in Section 9(a) for a direct competitor (either now or in the future) of the Company (any, a “Competitor”).

 

(b)
Solicitation of Employees. During the period in which the provision of Section 8(a) shall be in effect, the Executive agrees that
he shall not, directly or indirectly, request, recommend or advise any employee of the Company to terminate his or her employment with
the Company, for the purposes of providing services for a Competitor, or solicit for employment or recommend to any third party the solicitation
for employment of any individual who was employed by the Company or any of its subsidiaries and affiliates at any time during the one
year period preceding the Executive’s termination of employment.

 

(c)  
Non-disparagement. The Executive agrees that, after the end of his employment, he will refrain from making, in writing or orally,
any unfavorable comments about the Company, its operations, policies, or procedures that would be likely to injure the Company’s
reputation or business prospects; provided, however, that nothing herein shall preclude the Executive from responding truthfully
to a lawful subpoena or other compulsory legal process or from providing truthful information otherwise required by law.

 

    7

     

    

 

(d)  
No Payment. The Executive acknowledges and agrees that no separate or additional payment will be required to be made to
him in consideration of his undertakings in this Section 8, and confirms he has received adequate consideration for such undertakings.

 

(e)
References. References to the Company in this Section 8 shall include the Company’s subsidiaries and affiliates.

 

9.
Non-Disclosure of Confidential Information.

 

(a) 
Confidential Information. For purposes of this Agreement, “Confidential Information” includes, but is not limited to,
trade secrets, processes, policies, procedures, techniques, designs, drawings, know-how, show-how, technical information, specifications,
computer software and source code, information and data relating to the development, research, testing, costs, marketing, and uses of
the Services (as defined herein), the Company’s budgets and strategic plans, and the identity and special needs of the Company’s
employees, customers, vendors, and suppliers, databases, data, and all technology relating to the Company’s businesses, systems,
methods of operation, leads, marketing and advertising materials, methods and manuals and forms, all of which pertain to the activities
or operations of the Company, the names, home addresses and all telephone numbers and e-mail addresses of the Company’s directors,
employees, officers, executives, and former executives. In addition, Confidential Information also includes the names of employees and
contact persons for customers, vendors and suppliers including the identity of and telephone numbers, e-mail addresses and other addresses
of such persons. Confidential Information also includes, without limitation, Confidential Information received from the Company’s
subsidiaries and affiliates. For purposes of this Agreement, the following will not constitute Confidential Information (i) information
which is or subsequently becomes generally available to the public through no act or fault of the Executive, (ii) information set forth
in the written records of the Executive prior to disclosure to the Executive by or on behalf of the Company which information is given
to the Company in writing as of or prior to the date of this Agreement, and (iii) information which is lawfully obtained by the Executive
in writing from a third party (excluding any affiliates of the Executive) who lawfully acquired the confidential information and who did
not acquire such confidential information or trade secret, directly or indirectly, from the Executive or the Company or its subsidiaries
or affiliates and who has not breached any duty of confidentiality. As used herein, the term “Services” shall include all
services offered for sale and marketed by the Company during the Term. Services also includes any other services which the Company has
taken concrete steps to offer for sale, but has not yet commenced selling or marketing, during or prior to the Term. Services also
include any services disclosed in the Company’s latest Registration Statement, Form
10-K, Form 10-Q or Form 8-K (or successor form) filed with the Securities and Exchange Commission (the “SEC”).

 

(b)  
Legitimate Business Interests. The Executive recognizes that the Company has legitimate business interests to protect and
as a consequence, the Executive agrees to the restrictions contained in this Agreement because they further the Company’s legitimate
business interests. These legitimate business interests include, but are not limited to (i) trade secrets; (ii) valuable confidential
business, technical, and/or professional information that otherwise may not qualify as trade secrets, including, but not limited to, all
Confidential Information; (iii) substantial, significant, or key relationships with specific prospective or existing customers, vendors
or suppliers; (iv) Student goodwill associated
with the Company’s business; and (v) specialized training relating to the Company’s technology, Services, methods, operations
and procedures. Notwithstanding the foregoing, nothing in this Section 9(b) shall be construed to impose restrictions greater than those
imposed by other provisions of this Agreement.

 

(c)  
Confidentiality. During the Term of this Agreement and following termination of employment, for any reason, the Confidential
Information shall be held by the Executive in the strictest confidence and shall not, without the prior express written consent of the
Company, be disclosed to any person other than in connection with the Executive’s employment by the Company. The Executive further
acknowledges that such Confidential Information as is acquired and used by the Company or its subsidiaries or affiliates is a special,
valuable and unique asset. The Executive shall exercise all due and diligent precautions to protect the integrity of the Company’s
Confidential Information and to keep it confidential whether it is in written form, on electronic media, oral, or otherwise. The Executive
shall not copy any Confidential Information except to the extent necessary to his employment nor remove any Confidential Information or
copies thereof from the Company’s premises except to the extent necessary to his employment. All records, files, materials and other
Confidential Information obtained by the Executive in the course of his employment with the Company are confidential and proprietary and
shall remain the exclusive property of the Company. The Executive shall not, except in connection with and as required by his performance
of his duties under this Agreement, for any reason use for his own benefit or the benefit of any person or entity other than the Company
or disclose any such Confidential Information to any person, firm, corporation, association or other entity for any reason or purpose
whatsoever without the prior express written consent of an executive officer of the Company (excluding the Executive).

 

    8

     

    

 

(d)
References. References to the Company in this Section 9 shall include the Company’s subsidiaries and affiliates.

 

(e)  
Whistleblowing. Nothing contained in this Agreement shall be construed to prevent the Executive from reporting any act or failure
to act to the SEC or other governmental body or prevent the Executive from obtaining a fee as a “whistleblower” under Rule
21F-17(a) under the Securities Exchange Act of 1934 or other rules or regulations implemented under the Dodd-Frank Wall Street Reform
Act and Consumer Protection Act.

 

(f)  
Notice of Immunity Under the Economic Espionage Act of 1996, as amended by the Defend Trade Secrets Act of 2016. Notwithstanding
any other provision of this Agreement:

 

(1)
The Executive will not be held criminally or civilly liable under any federal or state trade secret law for any disclosure of a trade
secret that:

 

(A)
is made (1) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney;
and (2) solely for the purpose of reporting or investigating a suspected violation of law; or

 

(B)
is made in a complaint or other document filed under seal in a lawsuit or other proceeding.

 

(2)
If the Executive files a lawsuit for retaliation by the Company for reporting a suspected violation of law, the Executive may disclose
the Company’s trade secrets to the Executive’s attorney and use the trade secret information in the court proceeding if the
Executive:

 

		(A)	files any document containing trade secrets under seal; and

 

		(B)	does not disclose trade secrets, except pursuant to court order.

 

10.
Equitable Relief.

 

(a)  
The Company and the Executive recognize that the services to be rendered under this Agreement by the Executive are special, unique
and of extraordinary character, and that in the event of the breach by the Executive of the terms and conditions of this Agreement or
if the Executive, without the prior express consent of the Board, shall take any action in violation of Section 8 and/or Section 9, the
Company shall be entitled to institute and prosecute proceedings in any court of competent jurisdiction referred to in Section 10(b) below,
to enjoin the Executive from breaching the provisions of Section 8 and/or Section 9.

 

(b)  
Any action arising from or under this Agreement must be commenced only in the appropriate state or federal court located in New
York County, New York. The Executive and the Company irrevocably and unconditionally submit to the exclusive jurisdiction of such courts
and agree to take any and all future action necessary to submit to the jurisdiction of such courts. The Executive and the Company irrevocably
waive any objection that they now have or hereafter may have to the laying of venue of any suit, action or proceeding brought in any such
court and further irrevocably waive any claim that any such suit, action or proceeding brought in any such court has been brought in an
inconvenient forum. Final judgment against the Executive or the Company in any such suit shall be conclusive and may be enforced in other
jurisdictions by suit on the judgment, a certified or true copy of which shall be conclusive evidence of the fact and the amount of any
liability of the Executive or the Company therein described, or by appropriate proceedings under any applicable treaty or otherwise.

 

11.
Conflicts of Interest. While employed by the Company, the Executive shall not, unless approved by the Compensation Committee, directly
or indirectly:

 

(a)  
participate as an individual in any way in the benefits of transactions with any of the Company’s customers, vendors, or suppliers,
including, without limitation, having a financial interest in the Company’s customers, vendors, or suppliers, or making loans to,
or receiving loans, from, the Company’s customers, vendors, or suppliers;

 

    9

     

    

 

(b)
realize a personal gain or advantage from a transaction in which the Company has an interest or use information obtained in connection
with the Executive’s employment with the Company for the Executive’s personal advantage or gain; or

 

(c)  
accept any new offer during the Term to serve as an officer, director, partner, consultant, manager with, or to be employed in
a professional, technical, or managerial capacity by, a person or entity which does business with the Company other than ZEST.

 

12.
Inventions, Ideas, Processes, and Designs. All inventions, ideas, processes, programs, software, and designs (including
all improvements) (i) conceived or made by the Executive during the course of his employment with the Company (whether or not actually
conceived during regular business hours) and for a period of six months subsequent to the termination (whether by expiration of the Term
or otherwise) of such employment with the Company, and (ii) related to the business of the Company, shall be disclosed in writing promptly
to the Company and shall be the sole and exclusive property of the Company, and the Executive hereby assigns any such inventions to the
Company. An invention, idea, process, program, software, or design (including an improvement) shall be deemed related to the business
of the Company if (a) it was made with the Company’s funds, personnel, equipment, supplies, facilities, or Confidential Information,
(b) results from work performed by the Executive for the Company, or (c) pertains to the current business or demonstrably anticipated
research or development work of the Company. The Executive shall cooperate with the Company and its attorneys in the preparation of patent
and copyright applications for such developments and, upon request, shall promptly assign all such inventions, ideas, processes, and designs
to the Company. The decision to file for patent or copyright protection or to maintain such development as a trade secret, or otherwise,
shall be in the sole discretion of the Company, and the Executive shall be bound by such decision. The Executive hereby irrevocably assigns
to the Company, for no additional consideration, the Executive’s entire right, title and interest in and to all work product and
intellectual property rights, including the right to sue, counterclaim and recover for all past, present and future infringement, misappropriation
or dilution thereof, and all rights corresponding thereto throughout the world. Nothing contained in this Agreement shall be construed
to reduce or limit the Company’s rights, title or interest in any work product or intellectual property rights so as to be less in any
respect than the Company would have had in the absence of this Agreement. If applicable, the Executive shall provide as a schedule to
this Agreement, a complete list of all inventions, ideas, processes, and designs, if any, patented or unpatented, copyrighted or otherwise,
or non-copyrighted, including a brief description, which he made or conceived prior to his employment with the Company and which therefore
are excluded from the scope of this Agreement. References to the Company in this Section 12 shall include the Company, its subsidiaries
and affiliates.

 

13.
Indebtedness. If, during the course of the Executive’s employment under this Agreement, the Executive becomes indebted to
the Company for any reason, the Company may, if it so elects, and if permitted by applicable law, set off any sum due to the Company from
the Executive and collect any remaining balance from the Executive unless the Executive has entered into a written agreement with the
Company.

 

14.
Assignability. The rights and obligations of the Company under this Agreement shall inure to the benefit of and be binding
upon the successors and assigns of the Company, provided that such successor or assign shall acquire all or substantially all of the securities
or assets and business of the Company. The Executive’s obligations hereunder may not be assigned or alienated and any attempt to
do so by the Executive will be void.

 

15.
Severability.

 

(a)  
The Executive expressly agrees that the character, duration and geographical scope of the non-competition provisions set forth
in this Agreement are reasonable in light of the circumstances as they exist on the date hereof. Should a decision, however, be made at
a later date by a court of competent jurisdiction that the character, duration or geographical scope of such provisions is unreasonable,
then it is the intention and the agreement of the Executive and the Company that this Agreement shall be construed by the court in such
a manner as to impose only those restrictions on the Executive’s conduct that are reasonable in the light of the circumstances and
as are necessary to assure to the Company the benefits of this Agreement. If, in any judicial proceeding, a court shall refuse to enforce
all of the separate covenants deemed included herein because taken together they are more extensive than necessary to assure to the Company
the intended benefits of this Agreement, it is expressly understood and agreed by the parties hereto that the provisions of this Agreement
that, if eliminated, would permit the remaining separate provisions to be enforced in such proceeding shall be deemed eliminated, for
the purposes of such proceeding, from this Agreement.

 

    10

     

    

 

(b)  
If any provision of this Agreement otherwise is deemed to be invalid or unenforceable or is prohibited by the laws of the state
or jurisdiction where it is to be performed, this Agreement shall be considered divisible as to such provision and such provision shall
be inoperative in such state or jurisdiction and shall not be part of the consideration moving from either of the parties to the other.
The remaining provisions of this Agreement shall be valid and binding and of like effect as though such provisions were not included.

 

16.
Notices and Addresses. All notices, offers, acceptance and any other acts under this Agreement (except payment) shall be in writing,
and shall be sufficiently given if delivered to the addressees in person, by FedEx or similar receipted delivery, or next business day
delivery to the addresses detailed below (or to such other address, as either of them, by notice to the other may designate from time
to time), or by e-mail delivery (in which event a copy shall immediately be sent by FedEx or similar receipted delivery), as follows:

 

	To the Company:	 	Agora Digital Holdings, Inc.
	 	 	303 Pearl Parkway, Suite 200
	 	 	San Antonio, TX 78215
	 	 	Attention: Jay Puchir, CFO
	 	 	Email: jpuchir@agoradigital.com
	 	 	 
	With a copy to:	 	Nason, Yeager, Gerson, Harris & Fumero, P.A.
	 	 	Attn: Michael D. Harris, Esq.
	 	 	3001 PGA Blvd., Suite 305
	 	 	Palm Beach Gardens, Florida 33410
	 	 	Email: mharris@nasonyeager.com
	 	 	 
	To the Executive:	 	Email: bhoagland@agoradigital.com

 

17.
Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original but
all of which together shall constitute one and the same instrument. The execution of this Agreement may be by actual or facsimile signature.

 

18.
Attorneys’ Fees. In the event that there is any controversy or claim arising out of or relating to this Agreement, or to
the interpretation, breach or enforcement thereof, and any action or proceeding is commenced to enforce the provisions of this Agreement,
the prevailing party shall be entitled to reasonable attorneys’ fees, costs and expenses (including such fees and costs on appeal).

 

19.
Governing Law. This Agreement shall be governed or interpreted according to the internal laws of the State of Nevada without regard
to choice of law considerations and all claims relating to or arising out of this Agreement, or the breach thereof, whether sounding in
contract, tort, or otherwise, shall also be governed by the laws of the State of Nevada without regard to choice of law considerations.

 

20.
Entire Agreement. This Agreement constitutes the entire Agreement between the parties and supersedes all prior oral and written
agreements between the parties hereto with respect to the subject matter hereof. Neither this Agreement nor any provision hereof may be
changed, waived, discharged or terminated orally, except by a statement in writing signed by the party or parties against which enforcement
or the change, waiver discharge or termination is sought.

 

21.
Section and Paragraph Headings. The section and paragraph headings in this Agreement are for reference purposes only and shall
not affect the meaning or interpretation of this Agreement.

 

22.
Section 409A Compliance.

 

(a)  
This Agreement is intended to comply with Section 409A of the Internal Revenue Code of 1986, as amended (“Section 409A”),
or an exemption thereunder. This Agreement shall be construed and administered in accordance with Section 409A. Notwithstanding any other
provision of this Agreement to the contrary, payments provided under this Agreement may only be made upon an event and in a manner that
complies with Section 409A or an applicable exemption. Any payments under this Agreement that may be excluded from Section 409A either
as separation pay due to an involuntary separation from service (including a voluntary separation from service for good reason that is
considered an involuntary separation for purposes of the separation pay exception under Treasury Regulation 1.409A-1(n)(2)) or as a short-term
deferral shall be excluded from Section 409A to the maximum extent possible. For purposes of Section 409A, each installment payment provided
under this Agreement shall be treated as a separate payment. Any payments to be made under this Agreement upon a termination of employment
shall only be made if such termination of employment constitutes a “separation from service” under Section 409A.
Notwithstanding the foregoing, the Company makes no representations that the payments and benefits provided under this Agreement comply
with Section 409A and in no event shall the Company be liable for all or any portion of any taxes, penalties, interest, or other expenses
that may be incurred by the Executive on account of non-compliance with Section 409A.

 

    11

     

    

 

(b)
Notwithstanding any other provision of this Agreement, if at the time of the Executive’s termination of employment, the Executive is a
“specified employee”, determined in accordance with Section 409A, any payments and benefits provided under this Agreement that
constitute “nonqualified deferred compensation” subject to Section 409A (e.g., payments and benefits that do not qualify as
a short-term deferral or as a separation pay exception) that are provided to the Executive on account of the Executive’s separation
from service shall not be paid until the first payroll date to occur following the six-month anniversary of the Executive’s termination
date (“Specified Employee Payment Date”). The aggregate amount of any payments that would otherwise have been made during such
six-month period shall be paid in a lump sum on the Specified Employee Payment Date without interest and thereafter, any remaining payments
shall be paid without delay in accordance with their original schedule. If the Executive dies during the six-month period, any delayed
payments shall be paid to the Executive’s estate in a lump sum upon the Executive’s death.

 

(c)  
To the extent required by Section 409A, each reimbursement or in-kind benefit provided under this Agreement shall be provided in accordance
with the following:

 

(1)
the amount of expenses eligible for reimbursement, or in-kind benefits provided, during each calendar year cannot affect the expenses
eligible for reimbursement, or in-kind benefits to be provided, in any other calendar year;

 

(2)
any reimbursement of an eligible expense shall be paid to the Executive on or before the last day of the calendar year following the calendar
year in which the expense was incurred; and

 

(3)
any right to reimbursements or in-kind benefits under this Agreement shall not be subject to liquidation or exchange for another benefit.

 

 

(d)  
In the event the Company determines that the Executive is a “specified employee” within the meaning of Section 409A(a)(2)(B)(i)
of the Code at the time of the Executive’s separation from service, then to the extent any payment or benefit that the Executive
becomes entitled to under this Agreement on account of the Executive’s separation from service would be considered deferred compensation
subject to Section 409A as a result of the application of Section 409A(a)(2)(B)(i) of the Code, such payment shall not be payable and
such benefit shall not be provided until the date that is the earlier of (i) six months and one day after the Executive’s separation
from service, or (ii) the Executive’s death (the “Six Month Delay Rule”).

 

(1)  
For purposes of this subparagraph, amounts payable under the Agreement should not provide for a deferral of compensation subject to Section
409A to the extent provided in Treasury Regulation Section 1.409A-1(b)(4) (e.g., short-term deferrals), Treasury Regulation Section 1.409A-1(b)(9) (e.g., separation pay
plans, including the exception under subparagraph (iii)), and other applicable provisions of the Treasury Regulations.

 

(2)
To the extent that the Six Month Delay Rule applies to payments otherwise payable on an installment basis, the first payment shall include
a catch-up payment covering amounts that would otherwise have been paid during the six-month period but for the application of the Six
Month Delay Rule, and the balance of the installments shall be payable in accordance with their original schedule.

 

(3)  
To the extent that the Six Month Delay Rule applies to the provision of benefits (including, but not limited to, life insurance
and medical insurance), such benefit coverage shall nonetheless be provided to the Executive during the first six months following his
separation from service (the “Six Month Period”), provided that, during such Six-Month Period, the Executive pays to the Company,
on a monthly basis in advance, an amount equal to the Monthly Cost (as defined below) of such benefit coverage. The Company shall reimburse
the Executive for any such payments made by the Executive in a lump sum not later than 30 days following the sixth month anniversary of
the Executive’s separation from service. For purposes of this subparagraph, “Monthly Cost” means the minimum dollar
amount which, if paid by the Executive on a monthly basis in advance, results in the Executive not being required to recognize any federal
income tax on receipt of the benefit coverage during the Six Month Period.

 

(e)  
The parties intend that this Agreement will be administered in accordance with Section 409A. To the extent that any provision of
this Agreement is ambiguous as to its compliance with Section 409A, the provision shall be read in such a manner so that all payments
hereunder comply with Section 409A. The parties agree that this Agreement may be amended, as reasonably requested by either party, and
as may be necessary to fully comply with Section 409A and all related rules and regulations in order to preserve the payments and benefits
provided hereunder without additional cost to either party.

 

(f)  
The Company makes no representation or warranty and shall have no liability to the Executive or any other person if any provisions of
this Agreement are determined to constitute deferred compensation subject to Section 409A but do not satisfy an exemption from, or the
conditions of, such Section.

 

[Signature Page To Follow]

 

    12

     

    

 

IN WITNESS WHEREOF, the Company and
the Executive have executed this Agreement as of the date and year first above written.

 

	 	Agora Digital Holdings, Inc.
	 	 
	 	By:	/s/ Randy May
	 	Name: 	 Randy May
	 	Title:	 Executive Chairman
	 	 
	 	Executive:
	 	 
	 	/s/ William
    Hoagland
	 	Name:  	 William Hoagland

 

Signature Page to Employment Agreement

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00336-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00336-of-00352.parquet"}]]